Neuron-Specific Enolase (NSE) ELISA Kit

  • Created on the 11 May, 2017.


Human NSE ELISA kit is a method for analysing in vitro quantitative amounts of neuron specific enolase (gamma-enolase, ENO-2, NSE) in human serum samples. This assay has a minimum sensitivity limit of 0.19 ng/ml.


Neuron specific enolase (NSE) which can also be called gamma-enolase (ENO-2) or 2-phospho-D-glycerate hydrolase, is an isoenzyme belonging to the enolase family that consists up of α, β and γ subunits either has a homo or heterodimer. NSE is a 78 kD gamma-homodimer and the majority of this enolase-isoenzyme can be found in neuroendocrine and neuronal tissues. It is essentially a glycolytic enzyme that is able to catalyse the conversion of 2-phosphoglycerate into phosphoenolpyruvate. The biological half-life of NSE in body fluids is about 24 hours and due to the organ-specificity and concentrations of NSE in serum or cerebrospinal fluid (CSF), elevated levels have been identified in diseases which result in relative rapid neuronal destruction. The measurement of NSE concentration in serum of CSF has been useful in assisting the differential diagnosis of a variety of neurodegenerative and neuron-destructive disorders. The following NSE ELISA kit is not designed for screening test for neuroendocrine tumors but can be used to measure levels in established diagnosis. Neuron-specific enolase is useful tumor marker for lung cancer patients.


The minimum detection sensitivity level of gamma-enolase (neuron specific enolase, NSE, ENO-2) using current human NSE ELISA kit was 0.19 ng/ml. The dynamic range for this assay is 7.5 – 115.0 ng/ml.


  1. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Adv Exp Med Biol. (2015) 867: 125-43. Review. Isgrò M.A., et al.
  2. A systematic literature review of cerebrospinal fluid biomarkers in delirium. Dement Geriatr Cogn Disord. (2011) 32 (2): 79-93. Review. Hall R.J., et al.
  3. Antibodies to neuron-specific enolase for the delineation of the entire diffuse neuroendocrine system in health and disease. Semin Diagn Pathol. (1984) 1 (1): 59-70. Review. Carlei F. and Polak J.M.
  4. Clinical biochemistry of neuron specific enolase. Clin Chim Acta. (1989) 183 (1): 13-31. Review. Kaiser E., et al.
  5. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer. Eur J Cancer. (1994) 30A (5): 574-6. Review. Ledermann J.A.


  • Full Name: Neuron-Specific Enolase (NSE) ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum
  • Sensitivity: 0.19 ng/ml



Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford